Bicarbonate

Bicarbonate

SCHEMBL236889

O=C(O)O.O=C(O)c1ccccc1Oc1ccccc1.O=C(O)c1ccccc1Oc1ccccc1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.69
HTT P42858 2/20 0.61
ALDH1A1 P00352 7/20 0.59
SMN1; SMN2 Q16637 1/20 0.56
HSD17B10 Q99714 6/20 0.55
KDM4E B2RXH2 6/20 0.55
HPGD P15428 5/20 0.55
TSHR P16473 2/20 0.55
ESR1 P03372 1/20 0.55
ITGB3 P05106 1/20 0.55
ITGA2B P08514 1/20 0.55
HMGB1 P09429 1/20 0.55
GGT1 P19440 1/20 0.55
PTGS1 P23219 1/20 0.55
PTGS2 P35354 1/20 0.55
BLM P54132 1/20 0.55
NAPRT Q6XQN6 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
MAPT P10636 3/20 0.53
USP2 O75604 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL29943548 1.00 CTNNB1 (0.69) CTNNB1HTTALDH1A1SMN1; SMN2HSD17B10
Bicarbonate SCHEMBL21517637 1.00 CTNNB1 (0.69) CTNNB1HTTALDH1A1SMN1; SMN2HSD17B10
SCHEMBL1798 0.98 CTNNB1 (0.71) CTNNB1HTTALDH1A1SMN1; SMN2HSD17B10
SCHEMBL4129945 0.96 CTNNB1 (0.69) CTNNB1HTTALDH1A1SMN1; SMN2HSD17B10
SCHEMBL11407865 0.96 CTNNB1 (0.69) CTNNB1HTTALDH1A1SMN1; SMN2HSD17B10
SCHEMBL11875755 0.96 CTNNB1 (0.69) CTNNB1HTTALDH1A1SMN1; SMN2HSD17B10
Hydrochloric Acid SCHEMBL6648767 0.96 CTNNB1 (0.69) CTNNB1HTTALDH1A1SMN1; SMN2HSD17B10
SCHEMBL8496446 0.96 CTNNB1 (0.69) CTNNB1HTTALDH1A1SMN1; SMN2HSD17B10
SCHEMBL17888702 0.96 CTNNB1 (0.69) CTNNB1HTTALDH1A1SMN1; SMN2HSD17B10
SCHEMBL1537710 0.94 HTT (0.70) CTNNB1HTTALDH1A1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600116-B2 Special polymer layers for faster laminability of multilayer structures COVESTRO DEUTSCHLAND AG (DE) 2026-04-14 US disclosed
EP-3055342-B1 PROCESS FOR PREPARING POLYSILOXANE-POLYCARBONATE BLOCK COCONDENSATES USING A SALT OF A WEAK ACID COVESTRO DEUTSCHLAND AG (DE) 2026-03-04 EP disclosed
US-12365775-B2 Process for partial colouring of plastic parts using solid colourants in colour- carrier layers COVESTRO DEUTSCHLAND AG (DE) 2025-07-22 US disclosed
US-20250205963-A1 METHOD FOR PRODUCING A PLASTIC MOLDING tooz technologies GmbH (DE) 2025-06-26 US disclosed
EP-4549163-A2 IMPROVED METHOD FOR PARTIAL COLOURING OF PLASTIC PARTS Covestro Deutschland AG (DE) 2025-05-07 EP disclosed
EP-2593288-B2 APPARATUS AND PROCESS FOR PRODUCING PRODUCTS FROM PIGMENT-CONTAINING POLYMER MIXTURES COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2025-04-16 EP disclosed
US-20250091332-A1 FILM STRUCTURE SUITABLE FOR RAPID LAMINATION COVESTRO DEUTSCHLAND AG (DE) 2025-03-20 US disclosed
EP-3055344-B1 POLYSILOXANE-POLYCARBONATE BLOCK COCONDENSATES COVESTRO DEUTSCHLAND AG (DE) 2025-03-12 EP disclosed
EP-3840958-B1 IMPROVED METHOD FOR PARTIAL COLOURING OF PLASTIC PARTS COVESTRO DEUTSCHLAND AG (DE) 2025-02-19 EP disclosed
EP-4493388-A1 METHOD FOR PRODUCING A PLASTIC MOLDING tooz technologies GmbH (DE) 2025-01-22 EP disclosed
EP-1742983-A1 PROCESS FOR PRODUCING POLYCARBONATE Bayer MaterialScience AG (DE) 2007-01-17 EP disclosed
EP-1692205-A1 METHOD FOR PRODUCING POLYCARBONATES HAVING A LOW CONTENT OF VOLATILE COMPOUNDS ACCORDING TO THE TRANSESTERIFICATION PROCESS Bayer MaterialScience AG (DE) 2006-08-23 EP disclosed
US-7091302-B2 Process for the preparation of polycarbonate BAYER MATERIALSCIENCE AG (DE) 2006-08-15 US disclosed
US-20060004178-A1 Inhibition of catalytically active impurities in polycarbonate by the melt transesterification process COVESTRO DEUTSCHLAND AG (DE) 2006-01-05 US disclosed
EP-1612231-A1 Inhibition of catalyst-active impurities in polycarbonate transesterification process Bayer MaterialScience AG (DE) 2006-01-04 EP disclosed
US-20050288407-A1 Thermally stabilized polycarbonate composition BAYER MATERIALSCIENCE AG 2005-12-29 US disclosed
EP-1609818-A2 Heat stabilised polycarbonate compositions Bayer MaterialScience AG (DE) 2005-12-28 EP disclosed
WO-2005103115-A1 PROCESS FOR PRODUCING POLYCARBONATE BAYER MATERIALSCIENCE AG (DE) 2005-11-03 WO disclosed
US-20050239995-A1 Process for the preparation of polycarbonate BAYER MATERIALSCIENCE AG 2005-10-27 US disclosed
WO-2005054335-A1 METHOD FOR PRODUCING POLYCARBONATES HAVING A LOW CONTENT OF VOLATILE COMPOUNDS ACCORDING TO THE TRANSESTERIFICATION PROCESS BAYER MATERIALSCIENCE AG (DE) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600116-B2 Special polymer layers for faster laminability of multilayer structures ASH2L, SMC2, ELL CTNNB1 794/4885HTT 1662/4885ALDH1A1 4181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.